Hunan Fangsheng Pharmaceutical Co., Ltd.

Shanghai Stock Exchange 603998.SS

Hunan Fangsheng Pharmaceutical Co., Ltd. Market Capitalization on January 14, 2025: USD 564.66 M

Hunan Fangsheng Pharmaceutical Co., Ltd. Market Capitalization is USD 564.66 M on January 14, 2025, a -16.06% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

Hunan Fangsheng Pharmaceutical Co., Ltd. 52-week high Market Capitalization is USD 807.70 M on October 28, 2024, which is 43.04% above the current Market Capitalization.
Hunan Fangsheng Pharmaceutical Co., Ltd. 52-week low Market Capitalization is USD 448.34 M on February 05, 2024, which is -20.60% below the current Market Capitalization.
Hunan Fangsheng Pharmaceutical Co., Ltd. average Market Capitalization for the last 52 weeks is USD 663.57 M.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

Shanghai Stock Exchange: 603998.SS

Hunan Fangsheng Pharmaceutical Co., Ltd.

CEO	Ms. Xiaoli Zhou
IPO Date	Dec. 5, 2014
Location	China
Headquarters	No. 299, Jiayun Road
Employees	1,686
Sector	Health Care
Industries Pharmaceuticals

Description

Hunan Fangsheng Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products in China. It offers medicines in the form of tablets, capsules, and granules for cardiovascular and cerebrovascular, orthopedic, pediatric, gynecological, traumatology, and anti-infectives. The company was founded in 2002 and is based in Changsha, China.

Key trends

Past 5 years